Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 3
1982 2
1983 6
1984 3
1986 1
1987 2
1988 2
1989 5
1990 15
1991 17
1992 11
1993 25
1994 25
1995 27
1996 29
1997 41
1998 50
1999 61
2000 60
2001 96
2002 150
2003 165
2004 177
2005 238
2006 173
2007 217
2008 200
2009 156
2010 144
2011 188
2012 129
2013 154
2014 167
2015 136
2016 110
2017 99
2018 58
2019 20
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3,052 results
Results by year
Filters applied: . Clear all
Page 1
An Introduction to "Recent Trends in the Biotechnology Industry: Development and Manufacturing of Recombinant Antibodies and Proteins".
Pohlscheidt M, et al. Adv Biochem Eng Biotechnol 2018. PMID 29748871
The production of the first therapeutic proteins in the early 1980s heralded the launch of the biopharmaceuticals industry. The number of approved products has grown year on year over the past three decades to now represent a significant share of the entire pharmaceuticals market. ...
The production of the first therapeutic proteins in the early 1980s heralded the launch of the biopharmaceuticals industry. The numbe …
After Theranos
Waltz E. Nat Biotechnol 2017. PMID 28072783
Drug discovery in pharmaceutical industry: productivity challenges and trends.
Khanna I. Drug Discov Today 2012 - Review. PMID 22627006
Low productivity, rising R&D costs, dissipating proprietary products and dwindling pipelines are driving the pharmaceutical industry to unprecedented challenges and scrutiny. In this article I reflect on the current status of the pharmaceutical industry and reasons for continued low productivity. An emerging 'symbiotic model of innovation', that addresses underlying issues in drug failure and attempts to narrow gaps in current drug discovery processes, is discussed to boost productivity. ...
Low productivity, rising R&D costs, dissipating proprietary products and dwindling pipelines are driving the pharmaceutical industry
Development and Innovation of Ganoderma Industry and Products in China.
Li Z, et al. Adv Exp Med Biol 2019 - Review. PMID 31677144
Recent decades have witnessed the rapid development of Ganoderma industry, which is boosted through various efforts made by the government, the academia, and the industry. ...In the last section, several innovation trends are suggested for the further development of Ganoderma industry....
Recent decades have witnessed the rapid development of Ganoderma industry, which is boosted through various efforts made by the gover …
Moncef Slaoui
Slaoui M and Mullard A. Nat Rev Drug Discov 2015. PMID 26129795
Fragmentation in the biopharmaceutical industry.
Goldsmith AD and Varela FE. Drug Discov Today 2017 - Review. PMID 27816494
The large number of biopharmaceutical mergers and acquisitions (M&A) that occurred over the past decade has generated questions about whether the industry is consolidating around too-few players, negatively impacting both the number of medicines developed and overall innovation. However, closer examination of the level of biopharmaceutical consolidation by prescription sales shows that the industry was more fragmented in 2015 than in 2003. ...
The large number of biopharmaceutical mergers and acquisitions (M&A) that occurred over the past decade has generated questions about wh …
The year's new drugs and biologics 2018: Part II - News that shaped the industry in 2018.
Graul AI, et al. Drugs Today (Barc) 2019 - Review. PMID 30816887
This eagle's-eye overview of the drug industry in 2018 provides insight into some of last year's top stories, including a large and still growing outbreak of Ebola in the Democratic Republic of the Congo, as well as the potential uses (and abuses) of CRISPR technology. As in previous years, we also review orphan drug development, new regulatory agency-supported programs such as Priority Medicines Scheme (PRIME) and Sakigake, pipeline attrition, and pharma/biotech mergers and acquisitions of note. ...
This eagle's-eye overview of the drug industry in 2018 provides insight into some of last year's top stories, including a larg …
Phages of life - the path to pharma
Forde A and Hill C. Br J Pharmacol 2018 - Review. PMID 29266197 Free PMC article.
3,052 results
Jump to page
Feedback